These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6276064)

  • 41. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig.
    Duan J; Jaramillo J; Jung GL; McLeod AL; Fernandes BH; Mathis D
    Can J Physiol Pharmacol; 1995 Oct; 73(10):1512-8. PubMed ID: 8748944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent inhibition of angiotensin-converting enzyme by [des-Pro3]-bradykinin or "converstatin" in comparison with Captopril.
    Okuda M; Arakawa K
    J Biochem; 1985 Sep; 98(3):621-8. PubMed ID: 3003038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Converting enzyme inhibition during chronic angiotensin II infusion in rats: evidence against a non-angiotensin mechanism.
    Textor SC; Brunner HR; Gavras H
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():71s-74s. PubMed ID: 6256120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
    Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
    Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
    Fenoy FJ; Scicli G; Carretero O; Roman RJ
    Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
    Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries.
    Persson K; Andersson RG
    Eur J Pharmacol; 1999 Nov; 385(1):21-7. PubMed ID: 10594341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of the converting-enzyme inhibitor SQ 14 225 (captopril) in early one-kidney, one-clip hypertension in the rat.
    Vandongen R; Tunney A; Martinez P
    Clin Sci (Lond); 1981 Apr; 60(4):387-92. PubMed ID: 7018794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.
    Inada Y; Terashita Z; Imura Y; Tanabe M; Nishikawa K; Kikuchi S
    Jpn J Pharmacol; 1986 Sep; 42(1):99-108. PubMed ID: 3025487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats.
    Bennett MA; Thurston H
    Clin Sci (Lond); 1996 Jan; 90(1):21-9. PubMed ID: 8697701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of bradykinin potentiation in the antihypertensive effect of captopril in conscious rabbits with two-kidney, one-clip hypertension.
    Takata M; Sugimoto T; Matsumoto M; Iida H; Mizumura Y
    J Cardiovasc Pharmacol; 1981; 3(6):1260-8. PubMed ID: 6173526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin.
    Montenegro MF; Pessa LR; Tanus-Santos JE
    Eur J Pharmacol; 2009 Apr; 607(1-3):173-7. PubMed ID: 19233159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolongation by captopril of action potential duration in the normal and hypertrophied rat ventricle: direct action or inhibition of the local angiotensin converting enzyme?
    Ribuot C; Cardinal R; Gouin L; Moreau P; Godin D; Vermeulen M; de Champlain J; Rochette L; Nadeau R
    Cardiovasc Res; 1994 Feb; 28(2):221-7. PubMed ID: 8143304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of bradykinin and angiotensin in the regulation of blood pressure in conscious rats.
    van den Buuse M; Kerkhoff J
    Gen Pharmacol; 1991; 22(4):759-62. PubMed ID: 1936912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience.
    Rett K; Jauch KW; Wicklmayr M; Dietze G; Fink E; Mehnert H
    Postgrad Med J; 1986; 62 Suppl 1():59-64. PubMed ID: 3022274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment.
    Mullane KM; Moncada S
    Eur J Pharmacol; 1980 Sep; 66(4):355-65. PubMed ID: 6998710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bradykinin-induced dipsogenesis in captopril-treated rats.
    Fregly MJ; Rowland NE
    Brain Res Bull; 1991 Jan; 26(1):169-72. PubMed ID: 2015514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of bradykinin effects and inhibition of kininase activity in isolated smooth muscle.
    Schaffel R; Rodrigues MS; Assreuy J
    Can J Physiol Pharmacol; 1991 Jul; 69(7):904-8. PubMed ID: 1659490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced reactivity to bradykinin, angiotensin I and the effect of captopril in the pulmonary vasculature of chronically hypoxic rats.
    Russell PC; Emery CJ; Cai YN; Barer GR; Howard P
    Eur Respir J; 1990 Jul; 3(7):779-85. PubMed ID: 2261965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.